| Rib Removal and Pain in Partial Nephrectomy (NCT06543095) | TC Erciyes University | 2022-07-01 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. (NCT05363072) | Pfizer | 2022-05-02 |
| Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion (NCT05461027) | University Hospital, Strasbourg, France | 2022-05-01 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer (NCT05239533) | Memorial Sloan Kettering Cancer Center | 2022-02-16 |
| Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue (NCT06648902) | Kidney Cancer Research Bureau | 2022-02-01 |
| CARINAE for Stress Relief in Perioperative Care (NCT05184725) | Adhera Health, Inc. | 2022-01-10 |
| International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors (NCT05363657) | Azienda Ospedaliero-Universitaria Careggi | 2022-01-10 |
| Virtual 3D Modelling for Improved Surgical Planning of Robotic-assisted Partial Nephrectomy (NCT05109182) | Innersight Labs Ltd | 2022-01-01 |
| Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney (NCT06214000) | University Hospital, Strasbourg, France | 2021-12-20 |
| Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma (NCT05135832) | Herlev and Gentofte Hospital | 2021-12-13 |
| Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney Cancers (NCT04946266) | University Hospital, Strasbourg, France | 2021-12-01 |
| A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT05119335) | NiKang Therapeutics, Inc. | 2021-10-26 |
| Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer (NCT04922307) | Vanderbilt University Medical Center | 2021-07-23 |
| DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) (NCT04869462) | Aesculap AG | 2021-05-27 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (NCT04825834) | Delfi Diagnostics Inc. | 2021-03-22 |
| Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts (NCT04670887) | Helsinki University Central Hospital | 2021-03-15 |
| KidneyCare Cohort Study (KCC-S) (NCT06898632) | University of Utah | 2021-03-01 |
| Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell Carcinoma (NCT04669613) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-12-30 |
| Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) (NCT04508725) | Stanford University | 2020-12-05 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients (NCT04604158) | Gillian Gresham | 2020-12-02 |
| TDM for Optimized Outcome in Patients With mRCC. (NCT04659343) | Niels Fristrup | 2020-11-01 |
| Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging (NCT04021238) | UNC Lineberger Comprehensive Cancer Center | 2020-10-07 |
| (3D) Ultrasound Imaging Liver and Kidney (NCT03844399) | Western University, Canada | 2020-10-03 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy (NCT04329767) | Intuitive Surgical | 2020-09-18 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial (NCT03977571) | Niels Fristrup | 2020-07-06 |
| Participant Reported Outcomes and Treatment Experiences in Kidney Cancer (NCT04472663) | Bristol-Myers Squibb | 2020-07-06 |
| Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma (NCT04393350) | Emory University | 2020-06-22 |
| Cellular Immunity and Renal Cell Cancer (NCT04377113) | Clinical Hospital Center Rijeka | 2020-05-24 |
| To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer (NCT04342286) | Chinese University of Hong Kong | 2020-05-01 |
| Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer (NCT04337970) | Memorial Sloan Kettering Cancer Center | 2020-04-06 |
| Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma (NCT04260360) | NanOlogy, LLC | 2020-04-01 |
| Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health (NCT04000880) | University of Alabama at Birmingham | 2020-03-04 |
| Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response (NCT04146064) | University Health Network, Toronto | 2020-02-24 |
| ESP Block for Laparoscopic Nephrectomy Surgeries (NCT04085237) | McMaster University | 2020-01-04 |
| Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC) (NCT04222374) | University Hospital, Bordeaux | 2019-12-10 |
| Effect of Papaverine on Renal Artery Blood Flow Volume (NCT04162834) | Asan Medical Center | 2019-11-21 |
| An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy (NCT04623502) | University of Texas Southwestern Medical Center | 2019-09-30 |
| Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations (NCT03786796) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-03 |
| NeoVax Plus Ipilimumab in Renal Cell Carcinoma (NCT02950766) | Patrick Ott, MD, PhD | 2019-03-03 |
| Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery (NCT03824808) | University of Missouri-Columbia | 2019-02-26 |
| Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma (NCT03414827) | Zealand University Hospital | 2019-02-01 |
| Renal Cancer Detection Using Convolutional Neural Networks (NCT03857373) | Nessn Azawi | 2019-02-01 |
| Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas (NCT04415697) | Barretos Cancer Hospital | 2019-01-02 |
| A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) (NCT03634540) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-09-27 |
| A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread (NCT03663946) | Bristol-Myers Squibb | 2018-09-18 |
| Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases (NCT03520231) | University Health Network, Toronto | 2018-09-04 |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204) | Exact Sciences Corporation | 2018-08-23 |
| Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners (NCT03652298) | Centre Oscar Lambret | 2018-07-25 |
| HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma (NCT03354390) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-07-20 |
| Optimizing the Management of Patients With Oral Therapy (NCT03623490) | Centre Georges Francois Leclerc | 2018-05-22 |
| Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants (NCT03568435) | Bristol-Myers Squibb | 2018-02-14 |
| Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer (NCT03433534) | University Hospital, Tours | 2018-01-29 |
| Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer (NCT03455452) | Bristol-Myers Squibb | 2018-01-21 |
| Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer (NCT03308396) | Ajjai Alva, MD | 2017-12-19 |
| REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT (NCT01762592) | Heidelberg Pharma AG | 2017-12-01 |
| Development of Diagnostics and Treatment of Urological Cancers (NCT02994758) | Helsinki University Central Hospital | 2017-11-27 |
| Using Virtual Reality (VR) Models for Preoperative Planning (NCT03334344) | Ceevra, Inc. | 2017-10-24 |
| Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers (NCT03134027) | Duke University | 2017-10-19 |
| Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors (NCT03571438) | University Hospital, Grenoble | 2017-10-16 |
| Liquid Biopsy Evaluation and Repository Development at Princess Margaret (NCT03702309) | University Health Network, Toronto | 2017-08-03 |
| Project HERO: Health Empowerment & Recovery Outcomes (NCT03345563) | Rutgers, The State University of New Jersey | 2017-07-31 |
| Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents (NCT03185039) | Institut Paoli-Calmettes | 2017-05-29 |
| Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma (NCT03035630) | Guru Sonpavde | 2017-05-23 |
| Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy (NCT03323021) | MiMedx Group, Inc. | 2017-05-23 |
| SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients (NCT03065179) | University of Texas Southwestern Medical Center | 2017-03-01 |
| Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Partial Nephrectomy? (NCT04388917) | Centre Hospitalier Universitaire de Nice | 2017-01-01 |
| Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma (NCT02762006) | Moshe Ornstein | 2016-12-20 |
| A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) (NCT02974738) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-12-07 |
| Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (NCT02446795) | Consorzio Oncotech | 2016-11-01 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (NCT02669914) | Washington University School of Medicine | 2016-09-12 |
| Safety and Feasibility of IRE for SRMs (NCT02828709) | Dr. Prof. M.P. Laguna Pes | 2016-07-01 |
| Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy (NCT04120805) | University of Chicago | 2016-01-01 |
| Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer (NCT02821793) | Institut Bergonié | 2016-01-01 |
| Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma (NCT02687139) | Johns Hopkins University | 2015-10-01 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Protocol Active Surveillance Small Renal Masses (SRMs) (NCT03804320) | IRCCS San Raffaele | 2015-04-29 |
| Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique (NCT02511275) | Centre Hospitalier Universitaire de Saint Etienne | 2015-02-03 |
| A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) (NCT02293980) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-11-25 |
| Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) (NCT02060370) | M.D. Anderson Cancer Center | 2014-08-01 |
| A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. (NCT02186925) | Meir Medical Center | 2014-08-01 |
| Personal Web Page In Clinical Trial Participant Education (NCT03887091) | Dana-Farber Cancer Institute | 2014-07-21 |
| A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies (NCT02118337) | MedImmune LLC | 2014-05-19 |
| Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers (NCT02141490) | National Cancer Institute (NCI) | 2014-05-15 |
| RObotic PArtial Nephrectomy National Study (NCT03292549) | University Hospital, Bordeaux | 2014-04-01 |
| Perfusion Scanning's for Kidney Tumors (NCT01971905) | Nessn Azawi | 2014-02-01 |
| A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer (NCT02019693) | National Cancer Institute (NCI) | 2014-01-24 |
| Efficacy and Safety of IRE for RMs (NCT02298608) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-01-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Carfilzomib in Refractory Renal Cell Carcinoma (RCC) (NCT01775930) | M.D. Anderson Cancer Center | 2013-10-01 |
| Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy (NCT01894607) | M.D. Anderson Cancer Center | 2013-10-01 |
| Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC (NCT02143492) | Argos Therapeutics | 2013-08-01 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer (NCT01751529) | UNC Lineberger Comprehensive Cancer Center | 2013-05-01 |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) (NCT01392183) | M.D. Anderson Cancer Center | 2012-10-24 |